Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-11

Clinical Trial Update: A Study to Evaluate in Patients With Parkinsonian Type Disorders [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating a treatment in patients with Parkinson's disease, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chase Therapeutics Corporation | Conditions: Idiopathic Parkinson Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING